Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2014
08/14/2014WO2014122613A1 Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disorders
08/14/2014WO2014122298A1 Interleukin-4 inhibitors for the treamtent of neutropenia
08/14/2014WO2014122220A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/14/2014WO2014121840A1 Induced dendritic cells and uses thereof
08/14/2014WO2014121325A1 Il-11r binding proteins and uses thereof
08/14/2014WO2014100143A3 Liquid antibody formulation with improved aggregation properties
08/14/2014US20140227713 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
08/14/2014US20140227324 Use of an il12 receptor-beta 1 splice variant to diagnose active tuberculosis
08/14/2014US20140227323 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
08/14/2014US20140227321 Anti-viral compounds
08/14/2014US20140227320 Anti-viral compounds
08/14/2014US20140227316 Beta-lactam compounds for enhancing t cell-mediated immune responses
08/14/2014US20140227312 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines
08/14/2014US20140227309 Combination vaccine for respiratory syncytial virus and influenza
08/14/2014US20140227308 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
08/14/2014US20140227307 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
08/14/2014US20140227306 Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
08/14/2014US20140227305 Epstein-barr-virus vaccine
08/14/2014US20140227294 Prolactin receptor binding proteins and uses thereof
08/14/2014US20140227288 Pnmt as a novel marker for progenitor cells
08/14/2014US20140227279 Methods and compositions for the treatment of autoimmune and inflammatory diseases
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227276 Gpr177 as target and marker in tumors
08/14/2014US20140227275 Methods of treating and diagnosing pancreatitis
08/14/2014US20140227274 Prevention and Treatment of Amyloidogenic Disease
08/14/2014US20140227272 Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events caused by CD3-Specific Binding Domains
08/14/2014US20140227266 NOGO Receptor Antagonists
08/14/2014US20140227262 PD-1 Antagonists and Methods for Treating Infectious Disease
08/14/2014US20140227261 Use of omega fatty acids for treating disease
08/14/2014US20140227255 Combination therapy of anti-her3 antibodies
08/14/2014US20140227254 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
08/14/2014US20140227252 Methods and Monitoring of Treatment with a DLL4 Antagonist
08/14/2014US20140227250 Stable formulations of antibodies to tslp
08/14/2014US20140227186 Nanoparticle delivery compositions
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227178 Humanized Anti-HLA-DR Antibodies
08/13/2014EP2765192A1 Antigen-binding molecule for promoting clearance from plasma of antigen comprising saccharide chain receptor-binding domain
08/13/2014EP2765138A2 HIV-1 envelope glycoprotein
08/13/2014EP2765137A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/13/2014EP2764118A1 Wnt4 and med12 for use in the diagnosis and treatment of tumor diseases
08/13/2014EP2764026A2 Antibody specifically binding to epitope in sema domain of c-met
08/13/2014EP2764025A1 Ige anti -hmw-maa antibody
08/13/2014EP2764024A1 Anti c-met antibody and uses thereof
08/13/2014EP2764023A2 Anti-human sema4a antibodies useful to treat disease
08/13/2014EP2764022A1 Phosphospecific antibodies recognising tau
08/13/2014EP2764015A1 Influenza hemagglutinin variants
08/13/2014EP2763700A1 Human notch1 decoys
08/13/2014EP2763699A2 Vaccine
08/13/2014EP2763698A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof
08/13/2014EP2763697A1 Adjuvant compound
08/13/2014EP2763696A2 Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses
08/13/2014EP2763695A1 Adjuvanted formulations of staphylococcus aureus antigens
08/13/2014EP2763694A1 Production of a cysteine rich protein
08/13/2014EP2763687A1 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
08/13/2014EP2763671A2 Methods of treating age related disorders
08/13/2014EP2763666A1 Composition comprising bacillus calmette guerin with cox2 selective/preferential inhibitor and uses thereof
08/13/2014EP2650367A9 Human monoclonal antibody
08/13/2014CN103987730A 特异性结合c-met的sema域中表位的抗体 Specifically binds to c-met sema domain epitope
08/13/2014CN103987729A 癌胚抗原相关细胞粘附分子(ceacam)的抗体 Carcinoembryonic antigen-related cell adhesion molecule (ceacam) antibody
08/13/2014CN103987405A 抗pd-l1抗体及其用途 Antibodies and anti-pd-l1 use
08/13/2014CN103987404A 衣原体抗原组合物及其用途 Chlamydia antigen composition and use thereof
08/13/2014CN103981191A 一种抗cd20单链抗体的植物种子表达系统 An anti-cd20 single-chain antibody expression systems plant seeds
08/13/2014CN103981153A 伪狂犬病病毒双荧光标记缺失病毒的构建 Pseudorabies virus deletion construct double fluorescently labeled virus
08/13/2014CN103981151A 一种伪狂犬灭活疫苗及其制备方法 Pseudo rabies inactivated vaccine and its preparation method
08/13/2014CN103981150A 抗人b7-h4单克隆抗体及其制备和应用 B7-h4 anti-human monoclonal antibodies and their preparation and application
08/13/2014CN103981139A 一株布鲁氏菌弱毒株及其疫苗 An attenuated strain of Brucella and vaccines
08/13/2014CN103980364A 一种全人源抗her2单克隆抗体及其制备方法与应用 One kind of fully human monoclonal antibodies anti-her2 its preparation method and application
08/13/2014CN103980363A 人巨细胞病毒中和抗体及其应用 HCMV neutralizing antibodies and their application
08/13/2014CN103980361A 抗体 Antibody
08/13/2014CN103977425A 一种检测和评价分子和药物生物学功能的方法及其用途 A method for detecting and evaluating the biological function of the drug molecule and the method of its use
08/13/2014CN103977414A 一种冻干抗原活力稳定剂及其制备方法 A lyophilized antigen dynamic stabilizer and its preparation method
08/13/2014CN103977408A 整合素α<sub>M</sub>β<sub>2</sub>的拮抗剂在制备治疗血小板数量相关疾病的药物中的应用 Integrin α <sub> M </ sub> β <sub> 2 </ sub> antagonists used in the preparation of the treatment of diseases related to platelet counts in
08/13/2014CN103977404A 抗体制剂 Antibody preparations
08/13/2014CN103977403A 治疗溶血性疾病的方法 A method of treating a hemolytic disease
08/13/2014CN103977402A 治疗溶血性疾病的方法 A method of treating a hemolytic disease
08/13/2014CN103977401A 一种治疗多发性硬化的药物组合物 A method of treating multiple sclerosis in a pharmaceutical composition
08/13/2014CN103977400A 一种用细胞系生产鸡马立克氏病活疫苗的方法 A production cell lines Marek's disease live vaccine approach
08/13/2014CN103977399A 一种大鲵烂腿病病原菌灭活疫苗制备方法 One kind of salamander rotten leg disease pathogen inactivated vaccine preparation
08/13/2014CN103316337B 痘苗病毒载体基因修饰系统的建立及重组冠状病毒的应用 Establishment and application of recombinant coronavirus gene modified vaccinia virus vector system
08/13/2014CN103251960B 用于预防人或动物慢性弓形虫病的dna疫苗 Dna vaccine for the prevention of human or animal chronic toxoplasmosis
08/13/2014CN103184225B 一种多头带绦虫抗原基因及其重组蛋白与用途 One kind of long Taenia antigen gene and recombinant protein and uses
08/13/2014CN103088063B 一种表达狂犬病病毒g蛋白的重组假型杆状病毒及应用 A recombinant baculovirus and application pseudotyped rabies virus g protein expression
08/13/2014CN102746387B 一种hcv的dna疫苗及其制备方法 One kind of dna hcv vaccine and its preparation method
08/13/2014CN102657858B 一种肠道病毒疫苗的制备方法 A process for preparing virus vaccines intestinal
08/13/2014CN102633881B 针对her-3的抗体及其用途 For her-3 antibodies and uses thereof
08/13/2014CN102464718B 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 A humanized monoclonal antibody, the amino acid sequence of the nucleotide sequence and its use
08/13/2014CN102438652B 抗体制剂 Antibody preparations
08/13/2014CN102319417B 减轻内毒素的效应 Mitigate the effects of endotoxin
08/13/2014CN102258778B 生物分子表面展示及其用途 Biomolecular surface display and its use
08/13/2014CN102258772B 一种新的肿瘤树突状细胞治疗性疫苗的制备方法及其用途 A new tumor dendritic cell therapeutic vaccine preparation and use
08/13/2014CN102108355B 恶性疟原虫的多表位人工抗原及其用途 Plasmodium falciparum and its multi-purpose artificial antigen epitope
08/13/2014CN101928344B 抗cd20的人单克隆抗体 The human monoclonal antibody anti-cd20
08/13/2014CN101796073B 针对cxcr3的人源化抗体 For the humanized antibody cxcr3
08/12/2014US8802850 Cyclopropyl modulators of P2Y12 receptor
08/12/2014US8802836 Cloning and recombinant productions of Vespula venom protease and methods of use thereof
08/12/2014US8802827 AX1 PCSK9 antagonists
08/12/2014US8802826 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
08/12/2014US8802822 Polypeptides having antiviral activity and methods for use thereof
08/12/2014US8802820 Fc variants with altered binding to FcRn
08/12/2014US8802634 CD40-L Inhibitory Peptides
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 1823